159 related articles for article (PubMed ID: 35119702)
41. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
[TBL] [Abstract][Full Text] [Related]
43. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan.
Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T
J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.
Irtan S; Messahel B; Moroz V; Taylor RE; Grundy R; Kelsey A; Vujanic G; Pritchard-Jones K;
Radiother Oncol; 2019 Feb; 131():1-7. PubMed ID: 30773174
[TBL] [Abstract][Full Text] [Related]
45. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
Vujanić GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383760
[TBL] [Abstract][Full Text] [Related]
46. Clinical and biologic significance of nuclear unrest in Wilms tumor.
Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
[TBL] [Abstract][Full Text] [Related]
47. Multimodal therapy for adult Wilms' tumour: an experience from one centre.
Li JJ; Huang HH; Shen J; Jiang JY; Pan F; Yu ST; Kang Y; Zhao XX; Yan XC; Liang HJ
Clin Transl Oncol; 2011 Sep; 13(9):672-6. PubMed ID: 21865139
[TBL] [Abstract][Full Text] [Related]
48. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.
Vujanić GM; Parsons LN; D'Hooghe E; Treece AL; Collini P; Perlman EJ
Histopathology; 2022 Jun; 80(7):1026-1037. PubMed ID: 35275409
[TBL] [Abstract][Full Text] [Related]
49. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
50. Bilateral Wilms tumors: Treatment results from a single center.
Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T
Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721
[TBL] [Abstract][Full Text] [Related]
51. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
52. The effect of preoperative therapy on the histologic features of Wilms' tumor. An analysis of cases from the Third National Wilms' Tumor Study.
Zuppan CW; Beckwith JB; Weeks DA; Luckey DW; Pringle KC
Cancer; 1991 Jul; 68(2):385-94. PubMed ID: 1648997
[TBL] [Abstract][Full Text] [Related]
53. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
[TBL] [Abstract][Full Text] [Related]
54. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
Lovvorn HN; Renfro LA; Benedetti DJ; Kotagal M; Phelps HM; Ehrlich PF; Lo AC; Sandberg JK; Treece AL; Gow KW; Glick RD; Davidoff AM; Cost NG; Dix DB; Fernandez CV; Dome JS; Geller JI; Mullen EA
J Am Coll Surg; 2024 Apr; 238(4):733-749. PubMed ID: 38251681
[TBL] [Abstract][Full Text] [Related]
55. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
Maschietto M; Williams RD; Chagtai T; Popov SD; Sebire NJ; Vujanic G; Perlman E; Anderson JR; Grundy P; Dome JS; Pritchard-Jones K
PLoS One; 2014; 9(10):e109924. PubMed ID: 25313908
[TBL] [Abstract][Full Text] [Related]
56. Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution.
Rastegar B; Andersson N; Petersson A; Karlsson J; Chattopadhyay S; Valind A; Jansson C; Durand G; Romerius P; Jirström K; Holmquist Mengelbier L; Gisselsson D
Clin Cancer Res; 2023 Jul; 29(14):2668-2677. PubMed ID: 37140929
[TBL] [Abstract][Full Text] [Related]
57. Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.
Vujanić GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
Pediatr Dev Pathol; 2009; 12(2):111-5. PubMed ID: 18811224
[TBL] [Abstract][Full Text] [Related]
58. A higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: A study of 200 patients.
Rahiman EA; Trehan A; Jain R; Menon P; Kakkar N; Srinivasan R; Sodhi KS; Saxena AK; Kapoor R; Bansal D
Pediatr Blood Cancer; 2022 Nov; 69(11):e29880. PubMed ID: 35841309
[TBL] [Abstract][Full Text] [Related]
59. The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.
Jackson TJ; Williams RD; Brok J; Chowdhury T; Ronghe M; Powis M; Pritchard-Jones K; Vujanić GM;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27627. PubMed ID: 30761727
[TBL] [Abstract][Full Text] [Related]
60. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.
Weirich A; Leuschner I; Harms D; Vujanic GM; Tröger J; Abel U; Graf N; Schmidt D; Ludwig R; Voûte PA
Ann Oncol; 2001 Mar; 12(3):311-9. PubMed ID: 11332141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
